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1. Introduction 
The antidiuretic hormone vasopressin s a nonapep- 
tide containing one disulfide bridge and tyrosyl and 
phenylalanyl residues in position -2 and -3, respective- 
ly. 8-Lysine vasopressin (LVP) is found in pig and 
hippopotamus while 8-arginine vasopressin (AVP) 
occurs in several other mammals (man, ox, rat...). These 
pituitary polypeptides xert selective ffects on the 
permeability of the distal part of the mammalian eph- 
ron and on the active sodium transport and passive 
permeability o water and other low molecular weight 
molecules of the amphibian skin and bladder epithelial 
cells. These effects have been shown to result from a 
specific activation of an adenyl cyclase located within 
the membrane of the target cells (for review, see for 
instance [1 ] ). 
Either LVP or AVP is associated with oxytocin, a
related peptide, and carried in the post-hypophysis 
by a family of relatively small proteins, the neuro- 
physins [2], with which they form non covalent 
complexes [3]. 
The isotopic labelling of polypeptidi¢ hormones has 
been successfully applied, in this laboratory, to oxy- 
tocin [4], angiotensine II [5] and other compounds [6]. 
The principle is an iodination of the tyrosyl (or 
histidyl) residue(s) followed by catalytic substitution 
of the peptide bound iodine with tritium. 
In this report we describe asimilar procedure 
which produces, after purification by affinity 
chromatography on a column of bovine neurophysins 
immobilized on Agarose, ahighly radioactive com- 
pound (10 Ci/mmole) which exhibits all the biological 
and biochemical properties of the native hormone. 
This, obviously, provides avery useful tool for the 
examination of the molecular mechanisms by which 
this important biological compound interacts with 
neurophysins [7] and biological membranes. 
2. Results and discussion 
2.1. Iodination 
4 gmoles of 8-1ysine-vasopressin (as a hydrochloride, 
285 + 20 IU/mg; a generous gift from Dr. Guttmann, 
Sandoz) dissolved in 2 ml 0.1 M phosphate buffer pH 
6.0 were allowed to react with 15/maoles IC1 contain- 
ing traces of 12s IC1 in anhydrous methanol at 5 ° under 
continuous stirring. After 1 min a slight excess of 
Na2 $2 03 was rapidly added to the mixture in order 
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to stop the reaction and destroy unreacted iodine. 
Quantitative valuation of  iodine incorporation i to 
the peptide molecule was checked by paper electro- 
phoresis eparation of  free mineral from bound iodine 
[4]; 70% of the total iodine was found associated with 
the peptide. The reaction product was then passed 
through a Biogel P2 column (Biorad Laboratories) to 
remove salts and elution was performed with 1 mM 
acetic acid. After elution of  a first peak of UV absorb- 
ing material, 1% acetic acid was then used and a second 
peak of peptide was recovered. This represented rough- 
ly 80% of the total product and was used for further 
tritiation. UV absorption of the reaction product 
indicated the characteristic bathochromic shift of the 
tyrosyl ring after iodination [4, 5]. The behavior of 
this compound on thin-layer chromatography (cellu- 
lose plate MN 300; solvent system: n-butanol-acet ic 
ac id-water  (75:10:25, v/v) indicated the absence of 
any significant amount of impurity. 
Aliquots samples were counted for ~25I radioactiv- 
ity on a Saip Gammatic solid scintillation counter. 
About 2 iodine atoms were found incorporated per 
peptide molecule. 
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Fig. 2. Radiochromatogram of [3H]LVP. A tracer amount of 
the neurophysins-Sephar0se column eluate was spotted to- 
gether with 10 IU unlabeUed LVP on a cellulose plate. Elution 
profile of radioactivity (e -o -e )  and biological activity of the 
unlabelled LVP measured by the activation of pig kidney 
medulla denylate cyclase (o- -t~- D). 
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Fig. 1. Affinity chromatography on a neurophysins-Sepharose 
conjugate. Elution diagram obtained after the product of the 
tritiation reaction was applied at the top of a column contain- 
ing 5 ml of Sepharose-bound neurophysins in 0,1 M acetate 
buffer, pH 5.7. Elution was performed with the same buffer 
and peaks I and 11 were recovered. Then 0.1 N HCOOH pH 
2.5 was used and peak III eluted. 3H radioactivity was mea- 
sured on a 5 ~1 aliquot of each fraction. 12Sl radioactivity was 
evaluated on the total fraction volume (1 ml). 
190 
2.2. Tritiation 
The iodo derivative was lyophylized and then redis- 
solved in a minimum volume (about 0.5 ml) of 1% 
acetic acid. The solution placed in the special flask 
described elsewhere [4] was then frozen and 10 mg of 
10% palladium on alumina catalyst (Engelhardt and 
Co.) added. 10 Ci of pure tritium (Commissariat 
l'Energie Atomique) gas was then introduced at a 
pressure of 500 mm Hg. After the mixture was brought 
to room temp. the reaction was performed under 
stirring at 25 ° during 20 min. Tritium gas was removed 
and the labile hydrogens eliminated by successive 
washes and evaporations with large volumes of distilled 
water. Salts were then removed from the reaction prod- 
uct by passage through a Biogel P2 column in acetic 
acid using a similar stepwise lution as mentioned 
before (see sect. 2.1 .). In the second peak eluted with 
1% acetic acid a partial separation of compounds 
containing either aH or 3H and 12sI radioactivities 
was apparent. Since the separation could not be 
achieved by this method with a sufficient efficiency, 
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purification was attempted using affinity chromato- 
graphy. Tritium determination was made using a SL 
30 Intertechnique scintillation spectrometer. 
2.3. Purification and biological assays 
In this reaction mixture, the tritiated laeptide could 
be separated from other by-products, including 
halogenated derivatives, dimeric forms and others, by 
selective adsorption on a conjugate of bovine neuro- 
physins covalently bound to Agarose gel. This was 
prepared according to the general coupling technique 
of Axen and Emback [8] and Cuatrecasas [9]. 10 ml 
decanted Sepharose 4 B (Pharmacia, Uppsala) were 
activated by reaction with BrCN (2 g) at pH 11 in the 
ice bath during 8 min, then rapidly washed with cold 
0.1 M NaHCO3 and the coupling buffer (0.1 M phos- 
phate, pH 7.2). 10/amoles of bovine neurophysins [7] 
were then rapidly added to the activated gel and 
allowed to react at pH 7.2 at 4 ° during 24 hr. The 
product of the reaction was washed with 120 ml of the 
coupling phosphate buffer in order to remove the 
remaining uncoupled proteins. The latter fraction was 
evaluated to 5 tanoles by UV absorbance at260 nm 
assuming e = 3400 M -1 cm-1. 
The affinity absorbent was placed on a column and 
washed thoroughly by large volumes of the following 
solvents: 1000 ml each: phosphate 0.1 M buffer con- 
raining 0.5 M glycine at pH 7.1;0.1 M acetate, pH 5.7; 
0:1 NHCOOH; and again 0.1 M acetate pH 5.7. 
The adsorption of the tritiation reaction product 
on the Sepharose conjugate was performed in 0.1 M 
acetate at pH 5.7 optimal for binding of the vaso- 
pressin to neurophysins [7]. This product was first 
lyophylized then dissolved in a minimum volume of 
acetate buffer and applied at the top of the affinity 
absorbent column (5 ml). 
Elution was performed with the same buffer. In the 
void volume (peak I; fig. 1), 3 H and 12 s I radioactivi- 
ties were recovered as a single peak. Partially excluded 
from the adsorbant was another compound (peak II; 
fig. 1) containing both 3H and ~2sI radioactivities. 
This product was not identified with certainty: its 
chromatographical behavior suggests that it might 
be a monohalogenated derivative of LVP. When no 
significant amount of radioactivity could be measured 
in the column effluent, the acetate buffer was replaced 
with 0.1 N HCOOH pH 2.5 to displace the tritiated 
LVP from its complex with Sepharose-bound neuro- 
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F ig .  3. Pig kidney adenylate cyclase activation by [3H]LVP 
and unlabelled LVP. Pig kidney medulla membranes (0.2 mg) 
were incubated at 30 ° for 5 min in presence of: 100 mM 
Tris-HCl pH 8.0; 10 mM MgCI2; 0.25 mM ATP; 0.65 ~tCi [a2p] 
¢~ATP; 1 mM 3'-5'- AMP; 20 mM phosphocreatine; 100 pg 
creatine kinase, and LVP or [aH]LVP. Labelled 3'-5'- AMP 
was separated bythe aluminium oxide method of Ramachan- 
dran and Lee [11 ]. Values are the mean of two determinations. 
physins [7]. A single peak of 3H radioactivity (peak 
III; fig. 1) was then eluted without any measurable 
contamination by 12s I radioactivity. This represented 
about 50% of the total 3H radioactivity. 
The radiochemical purity of this product was con- 
trolled by thin-layer chromatography. 5/A aliquots of 
the labelled product (containing about 420,000 cpm) 
were spotted on cellulose plates together with 10 IU 
of unlabelled peptide. The chromatogram was devel- 
oped in a solvent system: n-butanol-pyridine-acetic 
acid-wate r ( 15:10:3:6, by vol.) for 8 hr. Then the 
chromatogram was separated in successive strips (1 cm 
width) and the peptide xtracted from the cellulose 
powder with 0.5 ml 5% acetic acid. After centrifugation, 
the concentration, radioactivity and biological poten- 
cies of the supernatants were determined. 
The radiochromatogram of the labelled peptide 
(fig. 2) reveals the absence of any labelled impurity 
and illustrates the identical behavior of the labelled 
and unlabelled molecules. 
2.4. Activation of the adenyl cyclase 
A low speed sediment of pig kidney medulla homo- 
genate was used as a source of adenylate cyclase. The 
enzyme activity was assayed as previously described 
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[10]. Activation of  the cyclase by the tritiated mate- 
rial was found perfectly comparable with the standard 
process obtained by action of the unlabelled peptide 
(fig. 3). 
2.5. Pressor activity 
The rat pressor activity of the tritiated material 
was measured according to Stiirmer [12]. A value of 
228 IU/mg, i.e. 80%, of the maximum biological activ- 
ity of the starting material was found; the concentra- 
tion of the peptide was measured by the Lowry's 
method [ 13 ] using unlabelled lysine.vasopressin as 
standard. The [a H]LVP presented a specific radioac- 
tivity of 10 Ci/mmole. 
Thus, this labelling technique leads to a rapid pre- 
paration of  tritiated LVP of high specific activity. The 
affinity chromatography purification step proved to 
be very selective in allowing the recovery of peptide 
molecules retaining the ability both to bind neuro- 
physins and to trigger the biological responses exam- 
ined here. This mettrod has been applied to the puri- 
fication of tritiated oxytocin [7] and could be extrap- 
olated to other neurophysin-binding peptides. 
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